Electroencephalographic characterisation of pentylenetetrazole-induced seizures in mice lacking the α4 subunit of the neuronal nicotinic receptor

Neuropharmacology

Volumn 44, Issue 2, 2003, Pages 234-243

  McColl, C D ^a   Horne, M K ^a   Finkelstein, D I ^a   Wong, J Y F ^a   Berkovic, S F ^b   Drago, J ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Animal models; Electroencephalograph; Epilepsy; Nicotinic; Pentylenetetrazole; Seizure

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; CHOLINERGIC RECEPTOR; LIGAND; NICOTINIC RECEPTOR; PENTETRAZOLE; RECEPTOR SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOSOMAL DOMINANT NOCTURNAL FRONTAL LOBE EPILEPSY; CONTROLLED STUDY; DESENSITIZATION; DRUG SENSITIVITY; ELECTROENCEPHALOGRAM; EPILEPSY; FEMALE; GENE MUTATION; GENOTYPE; GRAND MAL SEIZURE; IN VIVO STUDY; INJECTION; KNOCKOUT MOUSE; MALE; MORTALITY; MOUSE; NERVE CELL NETWORK; NEUROPROTECTION; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SEIZURE; SPIKE WAVE; STRAIN DIFFERENCE;

EID: 0037292982     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00369-6     Document Type: Article

References (39)

1. Alkondon M., Pereira E.F.R., Eisenberg H.M., Albuquerque E.X. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. Journal of Neuroscience. 20:2000;66-75.
2. Arana G.W. An overview of side effects caused by typical antipsychotics. Journal of Clinical Psychiatry. 61:(Suppl. 8):2000;5-11.
3. Berkovic S.F., Scheffer I.E. Autosomal dominant nocturnal frontal lobe epilepsy. Bazil C.W., Malow B.A., Sammaritano M.R. Sleep and Epilepsy: The Clinical Spectrum. 2002;217-221 Elsevier, Amsterdam.
4. Bertrand D., Changeux J.-P. Nicotinic receptor: a prototype of allosteric ligand-gated ion channels and its possible implications in epilepsy. Delgado-Escueta A.V., Wilson W.A., Olsen R.W., Porter R.J. Jasper's Basic Mechanisms of the Epilepsies. Advances in Neurology. vol. 79:1999;Lippincott, Williams and Wilkins, Philadelphia.
5. Bertrand S., Weiland S., Berkovic S.F., Steinlein O.K., Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. British Journal of Pharmacology. 125:1998;751-760.
6. De Feo M.R., Mecarelli O., Ricci G., Rina M.F. Effects of carbamazepine on bicuculline- and pentylenetetrazole-induced seizures in developing rats. Brain Development. 13:1991;343-347.
7. De Fusco M., Bechetti A., Patrignani A., Annesi G., Gambardella A., Quattrone A., et al. The nicotinic receptor β2 subunit is mutant in nocturnal frontal lobe epilepsy. Nature Genetics. 26:2000;275-276.
8. Elgoyhen A.B., Vetter D.E., Jatz E., Rothlin C.V., Heinemann S.F., Boulter J. α10: A determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Science USA. 98:2001;3501-3506.
9. Ferraro T.N., Golden G.T., Smith G.G., St Jean P., Schork N.J., Mulholland N., et al. Mapping loci for pentylenetetrazol-induced seizure susceptibility in mice. Journal of Neuroscience. 19:1999;6733-6739.
10. Figl A., Viseshakul N., Shafaee N., Forsayeth J., Cohen B.N. Two mutations linked to nocturnal frontal lobe epilepsy cause use-dependent potentiation of the nicotinic ACh response. Journal of Physiology (London). 513:1998;655-670.
11. Frazier C.J., Buhler A.V., Weiner J.L., Dunwiddle T.V. Synaptic potentials mediated via α-bungartotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal neurons. Journal of Neuroscience. 18:1998.
12. Gil Z., Connors B.W., Amitai Y. Differential regulation of neocortical synapses by neuromodulators and activity. Neuron. 19:1997;679-686.
13. Gioanni Y., Rougeot C., Clarke P.B., Lepouse C., Thierry A.M., Vidal C. Nicotinic receptors in the rat prefrontal cortex: increase in glutamate release and facilitation of mediodorsal thalamo-cortical transmission. European Journal of Neuroscience. 11:1999;18-30.
14. Gotti C., Fornasari D., Clementi F. Human neuronal nicotinic receptors. Progress in Neurobiology. 53:1997;199-237.
15. Grady S.R., Meinerz N.M., Cao J., Reynolds A.M., Picciotto M.R., Changeaux J.-P., et al. Nicotinic agonists stimulate acetylcholine release from mouse interpeduncular nucleus: a function mediated by a different nAChR than dopamine release from striatum. Journal of Neurochemistry. 76:2001;258-268.
16. Hefft S., Hulo S., Bertrand D., Muller D. Synaptic transmission at acetylcholine receptors in rat hippocampal organotypic cultures and slices. Journal of Physiology (London). 515:1998;769-776.
17. Hirose S., Iwata H., Akiyoshi H., Kobayashi K., Ito M., Wada K., et al. A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy. Neurology. 53:1999;1749-1753.
18. Huang R., Bell-Horner C.L., Dibas M.I., Covey D.F., Drewe J.A., Dillon G.H. Pentylenetetrazole-induced inhibition of recombinant γ-aminobutyric acid Type A (GABAA) receptors: mechanism and site of action. Journal of Pharmacology and Experimental Therapeutics. 298:2001;986-995.
19. Kuryatov A., Gerzanich V., Nelson M., Olale F., Lindstrom J. Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human alpha4beta2 nicotinic acetylcholine receptors. Journal of Neuroscience. 17:1997;9035-9047.
20. Le Novere N., Changeux J.-P. Molecular evolution of the nicotinic acetylcholine receptor: an example of a multigene family in excitable cells. Journal of Molecular Evolution. 40:1995;155-172.
21. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. Journal of Neuroscience. 17:1997;576-585.
22. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.-P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. Journal of Pharmacology and Experimental Therapeutics. 287:1998;648-657.
23. MacDermott A., Role L.W., Siegelbaum S.A. Presynaptic ionotropic receptors and the control of transmitter release. Annual Review of Neuroscience. 22:1999;443-485.
24. Maresceaux C., Micheletti G., Vergnes M., Depaulis A., Rumbach L., Warter J.M. A model of chronic spontaneous petit mal-like seizures in the rat: comparison with pentylenetetrazol-induced seizures. Epilepsia. 25:1984;326-331.
25. Matsushima N., Hirose S., Iwata H., Fukuma G., Yonetani M., Nagayama C., et al. Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor alpha4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes. Epilepsy Research. 48:2002;181-186.
26. Picard F., Bertrand S., Steinlein O.K., Bertrand D. Mutated nicotinic receptors responsible for Autosomal Dominant Nocturnal Frontal Lobe Epilepsy are more sensitive to carbamazepine. Epilepsia. 40:1999;1198-1209.
27. Picard F., Baulac S., Kahane P., Hirsch E., Sebastianelli R., Thomas P., et al. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain. 123:2000;1247-1262.
28. Porter J.T., Cauli B., Tsuzuki K., Lambolez B., Rossier J., Audinat E. Selective excitation of subtypes of neocortical interneurons by nicotinic receptors. Journal of Neuroscience. 19:1999;5228-5235.
29. Phillips H.A., Favre I., Kirkpatrick M., Zuberi S.M., Goudie D., Heron S.E., et al. CHRNB2 is the second acetylcholine receptor subunit associated with Autosomal Dominant Nocturnal Frontal Lobe Epilepsy. American Journal of Human Genetics. 68:2001;225-231.
30. Radcliffe K.A., Dani J.A. Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. Journal of Neuroscience. 18:1998;7075-7083.
31. 4 neuronal nicotinic acetylcholine receptor subunit knock-out mouse. Journal of Neuroscience. 20:2000;6431-6441.
32. Snead O.C., Depaulis A., Vergnes M., Maresceaux C. Absence epilepsy: advances in experimental animal models. Delgado-Escueta A.V., Wilson W.A., Olsen R.W., Porter R.J. Jasper's Basic Mechanisms of the Epilepsies. Advances in Neurology. vol. 79:1999;Lippincott, Williams and Wilkins, Philadelphia.
33. Steinlein O.K., Mulley J.C., Propping P., Wallace R.H., Phillips H.A., Sutherland G.R., et al. A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nature Genetics. 11:1995;201-203.
34. Steinlein O.K., Magnusson A., Stoodt J., Bertrand S., Weiland S., Berkovic S.F., et al. An insertion mutation of the CHRNA4 gene in a family with autosomal dominant nocturnal frontal lobe epilepsy. Human Molecular Genetics. 6:1997;943-947.
35. Tassinari C.A., Michelucci R. Familial frontal and temporal lobe epilepsies. Engel J., Pedley A. Epilepsy: A Comprehensive Textbook. 1997;Lippincott-Raven, Philadelphia.
36. Vidal C., Changeux J.P. Nicotinic and muscarinic modulations of excitatory synaptic transmission in the rat prefrontal cortex in vitro. Neuroscience. 56:1993;23-32.
37. Wong J.Y.F., Ross S.A., McColl C.D., Massalas J.S., Powney E., Finkelstein D.I., et al. Proconvulsant-induced seizures in α4 nicotinic acetylcholine receptor subunit knockout mice. Neuropharmacology. 43:2002;55-64.
38. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends in Neuroscience. 20:1997;92-98.
39. Xiang Z., Huguenard J.R., Prince D.A. Cholinergic switching within neocortical inhibitory networks. Science. 281:1998;985-988.